Background
Clinical observations or animal studies implicate enteric glial cells (EGC) in motility disorders, IBS, IBD, GI infections, post-operative ileus and slow transit constipation. Mechanisms underlying glial responses to inflammation in human GI tract are not understood. Our goal was to identify the ‘reactive human EGC phenotype’ induced by inflammation and probe its functional relevance.
Methods
Human EGC in culture from 15 GI-surgical specimens were used to study gene expression, Ca2+ and purinergic signaling by Ca2+/fluo-4 imaging and mechanosensitivity. A nanostring-panel of 107 genes was designed as a read out of inflammation, transcription, purinergic signaling, vesicular transport-protein, channel, antioxidant and other pathways. A 24 h treatment with lipopolysaccharide (LPS, 200μg/ml) and interferon-γ (10μg/ml) was used to induce inflammation and study molecular signaling, flow-dependent Ca2+ responses from 3ml/min to 10ml/min, ATP release and ATP responses.
Results
Treatment induced a ‘rhEGC phenotype’ and caused upregulation in mRNA transcripts of 58% of 107 genes analyzed. Regulated genes included inflammatory genes (54%/IP10;IFNγ;CxCl2;CCL3;CCL2;C3;s100B;IL1β;IL2R;TNFα;IL4;IL6;IL8;IL10;IL12A;IL17A;IL22; IL33), purine-genes (52%/AdoR2A;AdoR2B;P2RY1;P2RY2;P2RY6;P2RX3;P2RX7;AMPD3;ENTPD2;ENTPD3; NADSYN1), channels (40%/Panx1;CHRNA7;TRPV1;TRPA1), vesicular-transporters (SYT1,SYT2,SNAP25,SYP), transcription factors (relA/relB,SOCS3,STAT3,GATA_3,FOXP3), growth factors (IGFBP5;GMCSF), antioxidant-genes (SOD2;HMOX1), and enzymes (NOS2;TPH2;CASP3)(p<0.0001). Treatment disrupted Ca2+ signaling, ATP and mechanical/flow-dependent Ca2+ responses in hEGC. ATP release increased 5-fold and s100B decreased 33%.
Conclusions
The ‘rhEGC phenotype is identified by a complex cascade of pro-inflammatory pathways leading to alterations of important molecular and functional signaling pathways (Ca2+, purinergic, mechanosensory) that could disrupt GI motility. Inflammation induced a ‘purinergic switch’ from ATP to ADP/adenosine/UTP signaling. Findings have implications for GI infection, IBD, POI, motility and GI disorders.